LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 43.65 | 21.74 | 2143 | 3754 | 0.5708 | 0.8547 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 43.65 | 21.74 | 2210 | 3754 | 0.5887 | 0.8624 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 45.62 | 21.74 | 1989 | 4150 | 0.4792 | 0.8149 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 45.62 | 21.74 | 2433 | 4150 | 0.5861 | 0.8639 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 45.62 | 21.74 | 2361 | 4150 | 0.5688 | 0.8565 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 45.62 | 21.74 | 2511 | 4150 | 0.6049 | 0.8716 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 45.62 | 21.74 | 2321 | 4150 | 0.5592 | 0.8523 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 45.62 | 21.74 | 2402 | 4150 | 0.5787 | 0.8607 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 47.59 | 21.74 | 2134 | 4492 | 0.4751 | 0.8155 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 47.59 | 21.74 | 2570 | 4492 | 0.5721 | 0.8599 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 47.59 | 21.74 | 2416 | 4492 | 0.5378 | 0.8451 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 47.59 | 21.74 | 2617 | 4492 | 0.5826 | 0.8643 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 47.59 | 21.74 | 2432 | 4492 | 0.5414 | 0.8466 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 47.59 | 21.74 | 2542 | 4492 | 0.5659 | 0.8573 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 49.56 | 21.74 | 2316 | 4838 | 0.4786 | 0.8197 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 49.56 | 21.74 | 2789 | 4838 | 0.5764 | 0.8636 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 49.56 | 21.74 | 2576 | 4838 | 0.5324 | 0.8447 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 49.56 | 21.74 | 2814 | 4838 | 0.5816 | 0.8657 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 49.56 | 21.74 | 2635 | 4838 | 0.5446 | 0.8500 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 49.56 | 21.74 | 2770 | 4838 | 0.5725 | 0.8619 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 51.53 | 21.74 | 2349 | 5150 | 0.4561 | 0.8105 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 51.53 | 21.74 | 2976 | 5150 | 0.5778 | 0.8656 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 51.53 | 21.74 | 2515 | 5150 | 0.4883 | 0.8263 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 51.53 | 21.74 | 3028 | 5150 | 0.5879 | 0.8697 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 51.53 | 21.74 | 2828 | 5150 | 0.5490 | 0.8536 | MN20160310_N01 | L08 |